SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-000800
Filing Date
2018-01-19
Accepted
2018-01-18 18:52:05
Documents
5
Period of Report
2018-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20180118_8k.htm 8-K 27031
2 EXHIBIT 1.1 ex_103237.htm EX-1.1 236937
3 EXHIBIT 4.1 ex_103239.htm EX-4.1 115379
4 EXHIBIT 99.1 ex_103247.htm EX-99.1 15483
5 ex_103247.jpg GRAPHIC 4079
  Complete submission text file 0001437749-18-000800.txt   402037
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 18535086
SIC: 2834 Pharmaceutical Preparations